Breakthrough Properties Acquires Unused Pfizer Biomanufacturing Facility for $78 Million
Life sciences real estate firm Breakthrough Properties has acquired a 270,000-square-foot biomanufacturing plant in Everett, Washington, for $78 million, securing a 21-year lease with an unnamed biopharmaceutical firm.
